Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial
Antonina Mikocka‐Walus(Deakin University), Jane M. Andrews(Health Net), Peter A. Bampton(Flinders University), Patrick A. Hughes(Hanson Institute), Adrian Esterman(SA Health), David J. Hetzel(Royal Adelaide Hospital)
Cited by 84
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
A genetic linkage map of the bovine genome
|Nature Genetics|1994|539